Abstract
The Atlas™ Rat cDNA Expression Array (BD Biosciences, United States) has been used to analyze changes in the expression of 588 genes in rat brain cells in response to a single administration of Ladasten, a 2-aminoadamantane derivative that has psychostimulating and anxiolytic effects. The analysis of hybridization on macroarrays, confirmed by the results of real-time quantitative RT-PCR, has demonstrated that Ladasten alters the expression of 12 genes in the rat brain. The GAT3 and CARBH genes are presumed to be pharmacologically important targets of Ladasten. The changes in their activity explain the mechanisms of the anxiolytic and mood-stabilizing effects of the drug. Ladasten has been shown to induce the genes whose products are involved in various signal pathways (APC, Rb, PKCIP, and PMCA), as well as the genes of cytoskeletal proteins (Tubα1 and actin), synaptic proteins (SynIA&IB and PLP), and enzymes (Gapdh and NSE). The proteins encoded by these genes are presumably involved in compensatory and/or neuroplastic adaptation to the effects of Ladasten.
Similar content being viewed by others
REFERENCES
Morozov I.S., Artsimovich I.G., Fadeeva T.A. 1993. USSR Patent 1826906. Byull. Izobret. 25, 97.
Morozov I.S., Klimova N.V., Sergeeva S.A., Ivanova I.A., Barchukov V.G., Kovalev G.I., Pyatin B.M., Avdyunina N.I. 1999. Adamantane derivatives improving resistance to extreme influences. Vestn. Ross. Akad. Med. Nauk. 23, 28–32.
Morozov I.S., Efimova L.P., Salenko Yu.A. 2000. Effects of bromantane and Sydnocarb on the efficiency of longterm operant activity and its vegetative correlates in rats. Eksp. Klin. Farmakol. 63, 11–15.
Morozov I.S., Petrov V.I., Sergeeva S.A. 2001. Farmakologiya adamantanov (Pharmacology of Adamantane and Its Derivatives), Volgograd.
Kudrin V.S., Sergeeva S.A., Krasnykh L.M., Miroshnichenko I.I., Grekhova T.V., Gainetdinov R.R. 1995. Effect of bromantane on dopamin-and serotoninegric systems of the rat brain. Eksp. Klin. Farmakol. 58, 8–11.
Yarkova M.A., Voronin M.V., Morozov I.S. 2001. Abstr. 3rd Int. Conf. “Biological Basis of Individual Sensitivity to Psychotropic Drugs,” Suzdal, 2001, p. 169.
Grekhova T.V., Gainetdinov R.R., Sotnikova T.D., Krasnykh L.M., Kudrin V.S., Sergeeva S.A., Morozov I.S. 1995. Influence of bromantane, a new immunostimulant with a psychostimulating effect, on dopamine release and metabolism in the dorsal striatum of free-moving rats: A microdialysis analysis. Byull. Eksp. Biol. Med. 3, 302–304.
Vakhitova Yu.V., Yamidanov R.S., Seredenin S.B. 2004. Ladasten induces the expression of genes regulating dopamine synthesis in different structures of the rat brain. Eksp. Klin. Farmakol. 67, 7–11.
Guang Ch., Khondakar A., Hasanat A., Bebchuk J.M., Moore G., Clitz D., Manji H.K. 1999. Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants. Psychosomatic Med. 61, 599–617.
Vakhitova Yu.V., Salimgareeva M.Kh., Seredenin S.B. 2004. Effect of Ladasten on protein kinase C activity in rat brain cells. Eksp. Klin. Farmakol. 67, 12–15.
Vakhitova Yu.V., Salimgareeva M.Kh., Seredenin S.B. 2004. Effect of Ladasten on the activity of sAMP-dependent protein kinases and protein phosphorylation in rat brain cells. Eksp. Klin. Farmakol. 67, 7–9.
Applied Biosystems, ABI PRISM 7700 Sequence Detection System, User Bulletin no. 2, 2001.
Pfaffl M.W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, E45.
Freeman W.M., Robertson D.J., Vrana K.E. 2000. Chronic cocaine-mediated changes in non-human primate nucleus accumbens gene expression. Biotechniques. 29, 1042–1055.
Freeman W.M., Brebner K., Lynch W.J., Palet K.M., Robertson D.J., Roberts D.C.S., Vrana K.E. 2002. Changes in rat frontal cortex gene expression following chronic cocaine. Mol. Brain Res. 104, 11–20.
Sokolov B.P., Polesskaya O.O., Uhl G.R. 2003. Mouse brain gene expression changes after acute and chronic amphetamine. J. Neurochem. 84, 244–252.
Jayanthi S., McCoy M.T., Ladenheim B., Cadet J.L. 2002. Methamphetamine causes coordinate regulation of Src, Cas, Crk and Jun N-terminal kinase-Jun pathway. Mol. Pharmacol. 61, 1124–1131.
Freeman W.M., Brebner K., Lynch W.J., Robertson D.J., Roberts D.C.S., Vrana K.E. 2001. Cocaine-responsive gene expression changes in rat hippocampus J. Neurosci. 108, 371–380.
Dringen R., Gebhardt R., Hamprecht B. 1993. Glycogen in astrocytes: Possible function as lactate supply for neighboring cells. Brain Res. 623, 208–214.
Marangos P.J., Schmechel D.E. 1987. Neuron-specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu. Rev. Neurosci. 10, 269–295.
Hattori T., Takei N., Mizuno Y., Kato K., Kohsaka S. 1995. Neurotrophic and neuroprotective effects of neuron-specific enolase on cultured neurons from embryonic rat brain. Neurosci. Res. 21, 191–198.
Dastoor Z., Dreyer J.L. 2001. Potential role of nuclear translocation of glyceraldehyde 3-phosphate dehydrogenase in apoptosis and oxidative stress. J. Cell Sci. 114, 1643–1653.
Allaman I., Pellrin L., Magistrelli P.J. 2000. Protein targeting to glycogen (PTG) mRNA expression is stimulated by noradrenaline in mouse cortical astrocytes. Glia. 30, 282–391.
Akil H., Owens C., Gutstein H. 1998. Endogenous opioids: Overview and current issues. Drug Alcohol. Depend. 51, 127–140.
Kiefler B.L. 1995. Recent advances in molecular recognition and signal transduction of active peptides: Receptors for opioid peptides. Cell. Mol. Neurobiol. 15, 615–634.
Khaidarliu S.Kh. 1989. Neiromediatornye mekhanizmy adaptatsii (Neurotransmitter-Related Mechanisms of Adaptation). Chisinau.
Khalimov A.R., Nasyrov Kh.M., Sergeeva S.A. 1997. Effect of bromantane on serum cortisol and insulin levels. Zdravookhr. Bashkir. 3, 7–10.
Hook V.Y.H., LaGamma E.F. 1987. Product inhibition of carboxypeptidase H. J. Biol. Chem. 262, 12583–12588.
Rodriguez C., Braybon K.A., Brownstein M., Dixon J.E. 1984. Rat preprocarboxypeptidase H: Cloning, characterization, and sequence of the cDNA and regulation of the mRNA by corticotropin-releasing factor. J. Biol. Chem. 264, 5988–5995.
Berke J.D., Paletzki R.F., Aronson G.J., Hyman S.E., Gerfen C.R. 1998. A complex program of striatal gene expression induced by dopaminergic stimulation. J. Neurosci. 18, 5301–5310.
Masson J., Sagne C., Hamon M., Mestikawys E. 1999. Neurotransmitter transporters in the central nervous system. Pharmacol. Rev. 51, 439–464.
Voronina T.A., Seredenin S.B. 2002. Perspectives in the search for new anxiolytic drugs. Eksp. Klin. Farmakol. 5, 4–17.
Peng W., Simantov R. 2003. Altered gene expression in frontal cortex and midbrain of 3,4-methylene-dioxymethamphetamine (MDMA) treated mice: Differential regulation of GABA transporter subtypes. J. Neurosci. Res. 72, 250–258.
Ito C. 2002. Analysis of overall gene expression induced by amphetamine and phencyclidine: Novel targets for the treatment of drug psychosis and schizophrenia. Curr. Pharmaceut. Design. 8, 147–153.
Seredenin S.B., Miramedova A.G. 1999. Analysis of the spectrum of pharmacological properties of bromantane. Bull. Eksp. Biol. Med. 128, 529–531.
Boggs J.M., Mosarello M.A. 1978. Structural organization of the human myelin membrane. Biochim. Biophys. Acta. 515, 1–21.
MacMillan S.V., Ishiyma N., White G.F., Palaniyar N., Hallett F.R., Harauz G. 2000. Myelin basic protein component C1 in increasing concentrations can elicit fusion, aggregation, and fragmentation of myelin-like membranes. Eur. J. Cell Biol. 79, 327–335.
Kaplan M.R., Meyer-Franke A., Lambert S., Bennett V., Duncan I.D., Levinson S.R., Barres B.A. 1997. Induction of sodium channel clustering by oligodendrocytes. Nature. 386, 724–728.
Greengard P., Valtorta F., Czernik A.J., Benfenati F. 1993. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science. 259, 780–785.
Thiriet N., Ladenheim B., McCoy M.T., Cadet J.L. 2002. Analysis of Ecstasy (MDMA)-induced transcriptional responses in the rat cortex. FASEB J. 16, 1887–1894.
Wong M.-L., O’Kirwan F., Hannestad J.P., Irizarry K.J.L., Elashoff D., Licinio J. 2004. St John’s wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response. Mol. Psych. 9, 237–251.
Noailles D.A., Becher K.G., Wood W.H., Teichberg D., Cadet J.L. 2003. Methamphetamine-induced gene expression profiles in the striatum of male rat pups exposed to the drug in utero. Brain Res. Dev. Brain Res. 147, 153–162.
Yaffe M.B. 2002. How do 14-3-3 proteins work? Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett. 513, 53–57.
Carafoli E. 2002. Calcium signaling: A tale for all seasons. Proc. Natl. Acad. Sci. USA. 99, 1115–1122.
Author information
Authors and Affiliations
Additional information
__________
Translated from Molekulyarnaya Biologiya, Vol. 39, No. 2, 2005, pp. 276–285.
Original Russian Text Copyright © 2005 by Vakhitova, Yamidanov, Vakhitov, Seredenin.
Rights and permissions
About this article
Cite this article
Vakhitova, Y.V., Yamidanov, R.S., Vakhitov, V.A. et al. cDNA macroarray analysis of gene expression changes in rat brain after a single administration of a 2-aminoadamantane derivative. Mol Biol 39, 244–252 (2005). https://doi.org/10.1007/s11008-005-0035-7
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11008-005-0035-7